Recombinant Alpha-1 Antitrypsin (AlphaMed/Florida Gulf Coast University)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameRecombinant Alpha-1 Antitrypsin (AlphaMed/Florida Gulf Coast University)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionProtease inhibitorsAlpha-1-antiproteinase modulators
TargetsAlpha-1-antiproteinaseProtease
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlphaMed Pharmaceuticals Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlphaMed Pharmaceuticals CorpFlorida Gulf Coast University
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A